Automated Chemiluminometric Screening of Counterfeit Drugs of the Antituberculosis Agent PyrazinamidePRIOR, Joao A. V; SANTOS, Joao L. M; LIMA, José L. F. C et al.Journal of AOAC International. 2009, Vol 92, Num 3, pp 830-836, issn 1060-3271, 7 p.Article

Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosisWADE, Mary Margaret; YING ZHANG.Journal of medical microbiology. 2004, Vol 53, Num 8, pp 769-773, issn 0022-2615, 5 p.Article

Enhancement of the antituberculosis activity of weak acids by inhibitors of energy metabolism but not by anaerobiosis suggests that weak acids act differently from the front-line tuberculosis drug pyrazinamidePEIHUA GU; CONSTANTINO, Luis; YING ZHANG et al.Journal of medical microbiology. 2008, Vol 57, Num 9, pp 1129-1134, issn 0022-2615, 6 p.Article

Gene Sequencing for Routine Verification of Pyrazinamide Resistance in Mycobacterium tuberculosis: a Role for pncA but Not rpsAALEXANDER, David C; MA, Jennifer H; GUTHRIE, Jennifer L et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 11, pp 3726-3728, issn 0095-1137, 3 p.Article

Hepatotoxicity of Pyrazinamide : Cohort and Case-Control AnalysesCHANG, Kwok C; LEUNG, Chi C; YEW, Wing W et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 12, pp 1391-1396, issn 1073-449X, 6 p.Article

Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosisPIERRE-AUDIGIER, C; SURCOUF, C; CADET-DANIEL, V et al.The International journal of tuberculosis and lung disease. 2012, Vol 16, Num 2, pp 221-223, issn 1027-3719, 3 p.Article

Pyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant TuberculosisCHANG, Kwok-Chiu; LEUNG, Chi-Chiu; YEW, Wing-Wai et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 11, pp 5465-5475, issn 0066-4804, 11 p.Article

Réaction cutanée après une prise de pyrazinamide = Cutaneous reaction after pyrazinamide initiationMULLIEZ, P; MBASSI FOUDA, F.-L; ROY SAINT-GEORGES, F et al.Médecine et maladies infectieuses. 2011, Vol 41, Num 9, pp 499-500, issn 0399-077X, 2 p.Article

Simple fibroblast-based assay to test the Pyrazinamide susceptibility of Mycobacterium tuberculosisTAKII, Takemasa; HAMASAKI, Sonomi; HIRANO, Kazue et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 2, pp 804-807, issn 0066-4804, 4 p.Article

Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncALEMAITRE, N; SOUGAKOFF, W; TRUFFOT-PERNOT, C et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 7, pp 1761-1763, issn 0066-4804Article

Characterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and GermanyNAPIORKOWSKA, A; RÜSCH-GERDES, S; HILLEMANN, D et al.The International journal of tuberculosis and lung disease. 2014, Vol 18, Num 4, pp 454-460, issn 1027-3719, 7 p.Article

Polyvinylpyrrolidone-polycaprolactone block copolymer micelles as nanocarriers of anti-TB drugsVEEREN, Anisha; BHAW-LUXIMON, Archana; JHURRY, Dhanjay et al.European polymer journal. 2013, Vol 49, Num 10, pp 3034-3045, issn 0014-3057, 12 p.Article

Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosisFAHIMI, F; TABARSI, P; KOBARFARD, F et al.The International journal of tuberculosis and lung disease. 2013, Vol 17, Num 12, pp 1602-1606, issn 1027-3719, 5 p.Article

Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene SequencingWERNGREN, J; STUREGARD, E; JUREEN, P et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 3, pp 1253-1257, issn 0066-4804, 5 p.Article

Cytotoxicity decreasing effect and antimycobacterial activity of chitosan conjugated with antituberculotic drugsVAVRIKOVA, Eva; MANDIKOVA, Jana; TREJTNAR, František et al.Carbohydrate polymers. 2011, Vol 83, Num 4, pp 1901-1907, issn 0144-8617, 7 p.Article

Rapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assayZANETTI CAMPANERUT, Paula Aline; DIAS GHIRALDI, Luciana; ESPINOZA SPOSITTO, Fernanda Luisa et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 5, pp 1044-1046, issn 0305-7453, 3 p.Article

Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis InfectionTIANYU ZHANG; LI, Si-Yang; WILLIAMS, Kathy N et al.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 6, pp 732-737, issn 1073-449X, 6 p.Article

Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase ISAYAHI, Halimah; ZIMHONY, Oren; JACOBS, William R et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 16, pp 4804-4807, issn 0960-894X, 4 p.Article

Pyrazinamide-Diflunisal: A New Dual-Drug Co-CrystalEVORA, António O. L; CASTRO, Ricardo A. E; MARIA, Teresa M. R et al.Crystal growth & design. 2011, Vol 11, Num 11, pp 4780-4788, issn 1528-7483, 9 p.Article

Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assaySYRE, Heidi; ØVREAS, Kristi; GREWAL, Harleen M. S et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 4, pp 704-712, issn 0305-7453, 9 p.Article

Validation of an ultra-fast UPLC-UV method for the separation of antituberculosis tabletsNGUYEN, Dao T.-T; GUILLARME, Davy; RUDAZ, Serge et al.Journal of separation science. 2008, Vol 31, Num 6-7, pp 1050-1056, issn 1615-9306, 7 p.Article

Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosisEL-RIDY, M. S; MOSTAFA, D. M; SHEHAB, A et al.International journal of pharmaceutics. 2007, Vol 330, Num 1-2, pp 82-88, issn 0378-5173, 7 p.Article

Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant w-beijing Mycobacterium tuberculosis strainsDORMANDY, Jillian; SOMOSKOVI, Akos; KREISWIRTH, Barry N et al.Chest. 2007, Vol 131, Num 2, pp 497-501, issn 0012-3692, 5 p.Article

Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosisIBRAHIM, M; ANDRIES, K; LOUNIS, N et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 3, pp 1011-1015, issn 0066-4804, 5 p.Article

Treatment of tuberculosis of the cervical spine : Operative versus nonoperative : Tuberculosis of the SpineMOON, Myung-Sang; MOON, Jeong-Lim; KIM, Sung-Sim et al.Clinical orthopaedics and related research. 2007, Num 460, pp 67-77, issn 0009-921X, 11 p.Article